1886994-04-2

Basic information

• Product Name: ethyl 3-amino-1H-pyrazole-5-carboxylate
• Synonyms: ethyl 3-amino-1H-pyrazole-5-carboxylate;1H-pyrazole-5-carboxylic acid, 3-amino-, ethyl ester
• CAS NO: 1886994-04-2
• Molecular Formula: C6H9N3O2
• Molecular Weight: 155.15456
• Mol File: 1886994-04-2.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 391.9±22.0 °C(Predicted)
• Appearance: /
• Density: 1.318±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 12.32±0.10(Predicted)
• CAS DataBase Reference: ethyl 3-amino-1H-pyrazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-amino-1H-pyrazole-5-carboxylate(1886994-04-2)
• EPA Substance Registry System: ethyl 3-amino-1H-pyrazole-5-carboxylate(1886994-04-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 1886994-04-2(Hazardous Substances Data)

Downstream Products

• 1192313-67-9 ethyl 1-{2-[4-fluoro-3-(trifluoromethyl)phenyl]-2-oxoethyl}-3-iodo-1H-pyrazole-5-carboxylate 
• 348146-97-4 C₁₆H₁₁ClF₃N₃O₂ 
• 333761-06-1 C₁₆H₁₁F₄N₃O₂ 
• 362589-79-5 C₁₆H₁₁BrF₃N₃O₂ 
• 348150-92-5 C₁₇H₁₄F₃N₃O₂ 
• 609338-39-8 C₁₆H₁₂F₃N₃O₂ 

Relevant articles and documents

Ketone-substituted heterocyclic compound and anesthetic effect thereof

The invention discloses a ketone-substituted heterocyclic compound and an anesthetic effect thereof. Specifically provided are a compound represented by formula I, a pharmaceutically acceptable salt thereof, a stereoisomer thereof, or a deuterated derivative thereof. The ketone-substituted heterocyclic compound provided by the invention has a good central nervous system inhibition effect, can generate sedative, hypnotic and/or general anesthesia effects, and can control the epilepsy persistent state; the ketone-substituted heterocyclic compound also has the characteristics of quick response and quick recovery while maintaining excellent anesthetic activity; meanwhile, the ketone-substituted heterocyclic compound has almost no inhibition effect on the adrenal cortex function, has small sideeffects, solves the technical problems in the field, and provides a new choice for clinically screening and/or preparing sedative, hypnotic and/or general anesthesia medicines and medicines for controlling the epilepsy persistent state.